Edition:
United States

Kitasato Institute and Sumitomo Dainippon Pharma signs joint drug discovery research agreement


Tuesday, 24 Oct 2017 04:22am EDT 

Oct 24 (Reuters) - Sumitomo Dainippon Pharma Co Ltd <4506.T>:Says it and the Kitasato Institute have signed a joint drug discovery research agreement for infections caused by bacteria with antimicrobial resistance (AMR).